Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

Please provide your email address to receive an email when new articles are posted on . Weekly injectable is first new treatment for candidemia and invasive candidiasis in more than a decade. Rezzayo ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents ...

While most people recover from fungal infections like candidiasis, it can pose a serious risk for immuno-compromised patients ...

Since its discovery in 2009, Candida auris has emerged as a serious global health concern due to its drug resistance.

Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and Healthcare Products Regulatory Agency (MHRA) filing ...

Vulvovaginal candidiasis is a common infection that causes vaginal and vulvar irritation and itchiness, as well as discharge. Most women will experience vulvovaginal candidiasis (VVC) during their ...

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

Experts are warning about a multi-drug resistant fungus known as a “superbug,” which has been detected in Connecticut.